I would say that our results may help physicians and patients who do not accept euthanasia to have a goodclinicalpractice, so that no patient is forced to reach death in a symptomatic way.
Key capacities: establishing readily accessible formulation and scale-up development capacity, and building goodclinicalpractice clinical trial capacity in Africa and other malaria-endemic areas.